EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity

Yuhan Li, Xianwen Zhang, Wanbo Tai, Xinyu Zhuang, Huicheng Shi, Shumin Liao, Xinyang Yu, Rui Mei, Xingzhao Chen, Yanhong Huang, Yubin Liu, Jianying Liu und 7 weitere

eBioMedicine · 2024

DOI: 10.1016/j.ebiom.2024.105437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eBioMedicine, 2024. Verfasst von Yuhan Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, Tsinghua University-Peking University Joint Center for Life Sciences, School of Basic Medical Sciences, Tsinghua …. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Global dissemination of SARS-CoV-2 Omicron sublineages has provided a sufficient opportunity for natural selection, thus enabling beneficial mutations to emerge. Characterisation of these mutations uncovers the underlying machinery responsible for the fast transmission of Omicron variants and guides vaccine development for combating the COVID-19 pandemic. METHODS: Through systematic bioinformatics analysis of 496,606 sequences of Omicron variants, we obtained 40 amino acid substitutions that occurred with high frequency in the S protein. Utilising pseudoviruses and a trans-complementation system of SARS-CoV-2, we identified the effect of high-frequency mutations on viral infectivity and elucidated the molecular mechanisms. Finally, we evaluated the impact of a key emerging mutation on the immune protection induced by the SARS-CoV-2 VLP mRNA vaccine in a murine model. FINDINGS: We identified a proline-to-leucine substitution at the 1263rd residue of the Spike protein, and upon investigating the relative frequencies across multiple Omicron sublineages, we found a trend of increasing frequency for P1263L. The substitution significantly enhances the capacity for S-mediated viral entry and improves the immunogenicity of a virus-like particle mRNA vaccine. Mechanistic studies showed that this mutation is located in the FERM binding motif of the cytoplasmic tail and impairs the interaction between the S protein and the Ezrin/Radixin/Moesin proteins. Additionally, this mutation facilitates the incorporation of S proteins into SARS-CoV-2 virions. INTERPRETATION: This study offers mechanistic insight into the constantly increasing transmissibility of SARS-CoV-2 Omicron variants and provides a meaningful optimisation strategy for vaccine development against SARS-CoV-2. FUNDING: This study was supported by grants from the National Key Research and Development Plan of China (2021YFC2302405, 2022YFC2303200, 2021YFC2300200 and 2022YFC2303400), the National Natural Science Foundation of China (32188101, 32200772, 82422049, 82241082, 32270182, 82372254, 82271872, 82341046, 32100755 and 82102389), Shenzhen Medical Research Fund (B2404002, A2303036), the Shenzhen Bay Laboratory Startup Fund (21330111), Shenzhen San-Ming Project for Prevention and Research on Vector-borne Diseases (SZSM202211023), Yunnan Provincial Science and Technology Project at Southwest United Graduate School (202302AO370010). The New Cornerstone Science Foundation through the New Cornerstone Investigator Program, and the Xplorer Prize from Tencent Foundation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2COVID-19COVID-19 VaccinesAmino Acid SubstitutionHumansAnimalsMiceMutationVirus InternalizationAntibodies, ViralFemale

Stichwörter der Autor:innen

High-frequency mutationsSARS-CoV-2Spike variantsVirus entryVirus-like particle mRNA vaccine

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • New Cornerstone Science Laboratory, Tsinghua University-Peking University Joint Center for Life Sciences, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
  • Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen 518000, China. Electronic address: zhangxw@szbl.ac.cn.
  • Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen 518000, China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122…
  • Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
  • Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, China.

Zitieren

APA

Li, Y., Zhang, X., Tai, W., Zhuang, X., Shi, H., Liao, S., Yu, X., Mei, R., Chen, X., Huang, Y., Liu, Y., Liu, J., Liu, Y., Zhu, Y., Wang, P., Tian, M., Yu, G., Li, L., & Cheng, G. (2024). A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity. eBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105437

Vancouver

Li Y, Zhang X, Tai W, Zhuang X, Shi H, Liao S, et al. A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity. eBioMedicine. 2024. doi:10.1016/j.ebiom.2024.105437

BibTeX
@article{Li2024,
  author = {Li, Yuhan and Zhang, Xianwen and Tai, Wanbo and Zhuang, Xinyu and Shi, Huicheng and Liao, Shumin and Yu, Xinyang and Mei, Rui and Chen, Xingzhao and Huang, Yanhong and Liu, Yubin and Liu, Jianying and Liu, Yang and Zhu, Yibin and Wang, Penghua and Tian, Mingyao and Yu, Guocan and Li, Liang and Cheng, Gong},
  title = {A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity},
  journal = {eBioMedicine},
  year = {2024},
  doi = {10.1016/j.ebiom.2024.105437}
}
Kostenlos starten →